Related Experiment Videos

Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit

Oguz Dursun1, Volkan Hazar, Gulsun Tezcan Karasu

  • 1Department of Pediatrics, Pediatric Intensive Care Unit, Akdeniz University, Antalya, Turkey.

Insights

Pediatric intensive care unit (PICU) admissions for children with cancer have high mortality. The Pediatric Risk of Mortality Score (PRISM) III is a key predictor, but other factors also inform care decisions.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric oncology

Background:

  • Children with malignancies admitted to the pediatric intensive care unit (PICU) face high mortality and morbidity.
  • Assessing risk factors is crucial for predicting short-term outcomes in this vulnerable population.

Purpose of the Study:

  • To identify risk factors for short-term outcomes in pediatric cancer patients admitted to the PICU.
  • To evaluate the predictive performance of the Pediatric Risk of Mortality Score (PRISM) III in this cohort.

Main Methods:

  • Retrospective cohort study of 36 pediatric cancer patients admitted to the PICU between August 2004 and August 2007.
  • Analysis of mortality rates, PRISM III scores, and clinical variables including organ system dysfunction, sepsis, mechanical ventilation, and inotropic support.

Main Results:

  • The overall mortality rate was 55%, significantly higher than the general PICU mortality (12%).
  • Higher PRISM III scores, increased organ system dysfunction, sepsis, mechanical ventilation, and inotropic support were associated with increased mortality.
  • PRISM III score was an independent predictor of outcome, performing well in predicting mortality.

Conclusions:

  • PRISM III score is a valuable tool for predicting outcomes in pediatric cancer patients in the PICU.
  • Clinical factors like mechanical ventilation, inotropic support, and organ system dysfunction should also be considered in treatment decisions for these critically ill children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...